Vita Life Sciences Limited (ASX:VLS)
Australia
· Delayed Price · Currency is AUD 1.815
+0.065 (3.71%)
Apr 30, 2025, 10:50 AM AEST
Vita Life Sciences Revenue
In the year 2024, Vita Life Sciences had annual revenue of 79.51M AUD with 8.28% growth. Vita Life Sciences had revenue of 40.05M in the half year ending December 31, 2024, with 17.27% growth.
Revenue
79.51M
Revenue Growth
+8.28%
P/S Ratio
1.22
Revenue / Employee
227.16K
Employees
350
Market Cap
96.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 79.51M | 6.08M | 8.28% |
| Dec 31, 2023 | 73.43M | 6.54M | 9.78% |
| Dec 31, 2022 | 66.89M | 9.78M | 17.14% |
| Dec 31, 2021 | 57.10M | 10.62M | 22.85% |
| Dec 31, 2020 | 46.48M | 4.03M | 9.49% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 24.61B |
| Pro Medicus | 184.58M |
| Cochlear | 2.31B |
| Sonic Healthcare | 9.33B |
| Telix Pharmaceuticals | 783.21M |
| Ramsay Health Care | 17.12B |
| Ansell | 3.00B |
| Mesoblast | 9.16M |